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The functional potential of hematopoietic stem cells
(HSCs) declines during aging, and in doing so, sig-
nificantly contributes to hematopoietic pathophysi-
ology in the elderly. To explore the relationship
between age-associated HSC decline and the epige-
nome, we examined global DNAmethylation of HSCs
during ontogeny in combination with functional
analysis. Although the DNA methylome is generally
stable during aging, site-specific alterations of DNA
methylation occur at genomic regions associated
with hematopoietic lineage potential and selectively
target genes expressed in downstream progenitor
and effector cells. We found that age-associated
HSC decline, replicative limits, and DNA methylation
are largely dependent on the proliferative history of
HSCs, yet appear to be telomere-length independent.
Physiological agingandexperimentally enforcedpro-
liferation of HSCs both led to DNA hypermethylation
of genes regulated by Polycomb Repressive Com-
plex 2. Our results provide evidence that epigenomic
alterations of the DNA methylation landscape con-
tribute to the functional decline of HSCs during aging.
INTRODUCTION
Adult tissue-specific stem cells function to mediate homeostasis
and regenerative potential of organs and tissues. Because these
processes deteriorate with advanced age, stem cell decline has
been proposed to be amajor factor underlying aging-associated
degenerative and pathological attributes in various tissues
(Rossi et al., 2008; Van Zant and Liang, 2003). In the hematopoi-
etic system, advanced age is accompanied by onset of a number
of clinically significant conditions, including diminished compe-
tence of the adaptive immune system, reduced regenerative
potential, and markedly elevated incidences of myelogenous
diseases, including myelodysplastic syndromes and leukemias(Beerman et al., 2010b). Aging of the hematopoietic stem cell
(HSC) compartment is believed to centrally contribute to the
onset of these pathologies (Rossi et al., 2008; Van Zant and
Liang, 2003). The molecular basis for HSC aging is complex,
and multiple mechanistic drivers have been identified. These
include the following: deregulation of the molecular control of
lineage specification (Rossi et al., 2005), activation of inflamma-
tory signaling cascades (Chambers et al., 2007), loss of cell
polarity (Florian et al., 2012), dominance of lineage-biased HSC
clones (Beerman et al., 2010a; Challen et al., 2010; Dykstra
et al., 2011; Muller-Sieburg et al., 2004), and DNA damage accu-
mulation (Rossi et al., 2007; Ru¨be et al., 2011; Wang et al., 2012;
Yahata et al., 2011). It is clear, however, that these mechanisms
do not account for all of the cellular and molecular attributes
accompanying HSC aging, indicating that other mechanisms
must be involved.
Numerous studies have suggested a critical role for epigenetic
regulation of HSC central properties, including self-renewal and
multilineage differentiation (Oh and Humphries, 2012). Because
these stem cell properties are characteristically altered during
HSC aging (Rossi et al., 2008), this raises the possibility that
age-associated changes in the epigenomic landscape or in its
regulators may play a mechanistic role in HSC decline during
aging. This is supported by studies demonstrating age-associ-
ated deregulation of transcription at distinct chromosomal
regions (Chambers et al., 2007) and of gene sets involved in
myeloid and lymphoid lineage commitment in HSCs purified
from old mice and humans (Chambers et al., 2007; Pang et al.,
2011; Rossi et al., 2005), which suggests a mechanism involving
coordinated genome-wide regulatory control. That age-depen-
dent epigenomic alterations may be involved in mediating such
changes is supported by evidence showing that genes involved
in mediating higher-order chromatin structure, chromatin re-
modeling, and epigenetic regulation are deregulated in HSCs
during aging (Chambers et al., 2007; Rossi et al., 2005).
Here, we have investigated the role alterations of the epige-
nomic landscape play during HSC aging by examining global
DNA methylation in these rare stem cells during ontogeny. We
show that DNA methylation changes during HSC aging occur
at regions associated with lineage potential and principally target
genes expressed downstream of HSCs. We also demonstrateCell Stem Cell 12, 413–425, April 4, 2013 ª2013 Elsevier Inc. 413
Figure 1. The Functional Potential of HSCs during Ontogeny Is Accompanied by Locus Specificity in the DNA Methylation Landscape
(A) Schematic overview of experimental design.
(B–D) Competitive transplantation of 100 HSCs from fetal liver (FL), young donors (Y), and old donors (O) (n = 8 recipients each) showing (B) total reconstitution, (C)
contribution to B cells (B220+) and myeloid (Mac1+) and T cells (CD3+), and (D) granulocyte chimerism at indicated time points.
(E) Bone marrow reconstitution 20 weeks posttransplant of recipients described in (B)–(D).
(F) Hierarchical clustering of representative 1 kb tiles of DNA methylation data of FL-HSCs, young HSCs, and old HSCs.
(G) Bean plots of global DNA methylation of FL-HSCs, young HSCs, and old HSCs.
(H) Number of 1 kb tiles with significant methylation differences in pairwise comparisons between HSCs isolated from different stages of ontogeny. Total
comparisons with sufficient DNA methylation data from both populations: FL-Y = 98,112, Y-O = 98,635.
(I and J) Chromatin enrichment of regions with significant methylation changes from FL-HSCs to young HCs (I) and young to old HSCs (J) showing Q values and
Log2Odds scores.
Significant differences: *p < 0.05, **p < 0.01, ***p < 0.001 (t test). Error bars show SEM. See also Figures S1 and S2, Table S1, Table S2, Table S3, and Table S4.
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differential DNA methylation are dependent on the divisional
history of HSCs and concomitant with selective hypermethyla-
tion of loci that are normally regulated by Polycomb Repressive
Complex 2 (PRC2). Our results are consistent with a central
mechanistic role for age-associated epigenetic alterations in
mediating the functional decline of HSCs during aging.
RESULTS
The Functional Potential of HSCs during Ontogeny Is
Accompanied by Specific DNA Methylation Alterations
To explore the possibility that epigenomic alterations play a role
in mediating age-associated HSC functional decline, we purified414 Cell Stem Cell 12, 413–425, April 4, 2013 ª2013 Elsevier Inc.HSCs from different stages of ontogeny from fetal development
through to old age using stringent cell surface criteria (Fig-
ure S1A available online) and, in parallel, subjected them to
functional assays and genome-wide DNA methylation analysis
(Figure 1A). To address functional potential, 100 HSCs from
E14.5 fetal liver (FL) and adult bone marrow (BM) of young
(3.5-month-old) and old (25-month-old) mice were competitively
transplanted into lethally irradiated congenic recipients. Periph-
eral blood analysis at monthly intervals showed that while
FL-HSCs had a slight but significant short-term repopulation
advantage over HSCs from young mice, by 16 weeks posttrans-
plant the HSCs from these two stages of ontogeny were compa-
rable in terms of their total repopulating potential (Figures 1B and
S1B) and in their ability to give rise to lymphoid and myeloid
Cell Stem Cell
DNA Methylation Changes Underlie HSC Agingeffector cells (Figures 1C and 1D). In contrast, HSCs from old
mice had impaired total reconstituting potential both short-
term (4 weeks) and long-term (16 weeks) posttransplant (Figures
1B and S1B). Consistent with previous reports comparing young
and old HSCs (Rossi et al., 2005; Sudo et al., 2000), the lineage
potential of HSCs from old mice was skewed toward myeloid
reconstitution, whereas FL-HSCs and young HSCs showed
balanced reconstitution (Figure 1C). Granulocyte chimerism
analysis, which can be used as a surrogate to measure ongoing
HSC potential (Bryder et al., 2006), revealed that whereas
FL-HSCs and young HSCs showed comparable activity
throughout the transplantation time course, aged HSCs showed
markedly diminished activity at all time points, consistent with
a significant loss of functional potential (Figures 1D and S1B).
BM analysis of recipient mice 5 months posttransplant showed
that whereas FL-HSCs and young HSCs were again functionally
comparable, both far exceeded the old HSCs in their ability to
reconstitute the BM (Figure 1E). In contrast, reconstitution of
the primitive stem/progenitor compartment, including pheno-
typic HSCs and Flk2multipotent progenitors (MPPFlk2, some-
times referred to as ST-HSCs), was comparable regardless of
donor age (Figure S1C) consistent with previous reports demon-
strating the sustained potential of old HSCs to reconstitute the
primitive stem cell compartment (Rossi et al., 2005). However,
in line with their diminished lymphoid lineage potential (Fig-
ure 1C), old HSCs poorly reconstituted the more committed
Flk2+ multipotent progenitors (MPPFlk2+), which include the
lymphoid-primed multipotent progenitor (LMPP) subpopulation
(Adolfsson et al., 2005) (Figure S1C).
Genome-wide DNAmethylation analysis using reduced repre-
sentation bisulfite sequencing (RRBS) was performed in parallel
on the HSCs purified from FL and adult young and old BM,
which provided single-CpG-resolution data from these rare
populations (Gu et al., 2011; Smith et al., 2012). DNA methy-
lation measurements were obtained from, at minimum, two
biological replicates (Table S1). Resulting data sets covered
most CpG islands and annotated gene promoters and provided
a representative sampling of putative enhancers and CpG island
shores. Consistent with the established reproducibility of the
technology (Bock et al., 2010; Meissner et al., 2008), we
observed excellent correlation (Pearson’s r > 0.98) between all
biological replicates when the data was analyzed either at the
nucleotide level or as 1 kb genomic tiles (Figure S2A and Table
S2). Strikingly, pairwise comparisons between FL-HSCs, young
HSCs, and old HSCs were highly correlated (Pearson’s r > 0.97),
indicating that the DNA methylation landscape is largely stably
maintained during HSC ontogeny (Figure S2B and Table S2).
Despite this overall similarity, however, hierarchical clustering
analysis of the methylation profiles showed that HSCs from
defined stages of ontogeny clustered independently, which
indicated unique age-associated methylation signatures (Fig-
ure 1F). Interestingly, a slight but significant increase in global
methylation was evident in the HSCs isolated from old mice
(Figure 1G), an observation that stands in marked contrast to
the results of a number of studies reporting global DNA hypo-
methylation in aged somatic cells and tissues from diverse
species (Gonzalo, 2010).
To define the differences contributing to the unique age-
associated DNA methylation signatures, we conducted pairwisecomparisons that led to the identification of several thousand
loci that significantly gained or lost DNA methylation during
HSC ontogeny (Figures 1H and S2C and Table S3 and Table
S4). These methylation differences mapped throughout the
genome and showed limited enrichment to specific chromo-
somal regions (Figure S2D), though they tended to cluster at
regions with high guanine-cytosine (GC) content, as expected
(Figure S2E). To address how these changes in DNAmethylation
might impact the function of HSCs during ontogeny, we analyzed
the differentially methylated DNA regions identified during HSC
ontogeny in comparison to genomic features functionally anno-
tated by ENCODE (Thomas et al., 2007) and defined in other
publicly available data sets, as we previously described (Bock
et al., 2012). Genomic regions that gained methylation in the
transition from FL-HSCs to young HSCs were significantly en-
riched for regions of open chromatin in nonhematopoietic cells,
including DNase hotspots in embryonic stem cells, brain, kidney,
and lung, in nonhematopoietic cells, whereas regions that lost
DNA methylation during this transition were enriched for regions
of open chromatin in blood cells (Figure 1I). Nonetheless, the
observed methylation differences between FL-HSCs and young
HSCs do not appear to significantly influence hematopoietic
potency because HSCs from FL and young mice exhibited
near equal potential in the transplantation assays we performed
(Figures 1B–1E). In contrast, the DNA methylation differences
between young and old HSCs localized to genomic regions
that more readily reflected the differences observed in lineage
potential of aged HSCs both at steady state (Figure S1D) and
after transplantation (Figure 1C). For example, increased DNA
methylation during this transition was enriched at regions of
open chromatin in erythroid, B, and T cells, whereas loss of
methylation was enriched at regions of open chromatin in
myeloid cells (Figure 1J). These observations are consistent
with the idea that locus-specific DNA methylation alterations,
by restricting access to chromatin regions associated with these
lineages, contribute to the diminished lymphoid and erythrocyte
potential of old HSCs (Figures 1C and S1D). In contrast, no
obvious link between differential DNAmethylation and the dimin-
ished total reconstituting potential of HSCs from old mice was
evident. This suggests that this latter aspect of HSC aging may
be more strictly under the control of different mechanistic
drivers, such as DNA damage accrual (Mandal et al., 2011).
DNAMethylation Changes duringHSCOntogeny Largely
Target Genes Expressed in Downstream Hematopoietic
Progeny
To examine the relationship between ontogeny-associated HSC
DNA methylation changes and gene expression, we performed
genome-wide expression profiling on HSCs purified from FL
and young and old mice. Hierarchical clustering analysis of the
resulting expression profiles revealed that HSCs from these
defined stages of ontogeny clustered separately (Figure 2A),
and similar to the methylation profiles (Figure 1F), HSCs from
young and old mice clustered more tightly to each other than
to FL-HSCs. This analysis revealed complex age-associated
expression patterns of genes, including Dnmt1, Dnmt3a and
Dnmt3b, Tet1, Tet2, andUhrf1, involved in mediating DNAmeth-
ylation dynamics (Figure S3A). Differentially expressed genes
were then globally defined (fold change R 2.0, p % 0.001,Cell Stem Cell 12, 413–425, April 4, 2013 ª2013 Elsevier Inc. 415
Figure 2. DNA Methylation Changes during HSC Ontogeny Largely Target Genes Expressed in Downstream Hematopoietic Progeny
(A) Hierarchical clustering of representative expression profiles of FL-HSCs, young HSCs, and old HSCs.
(B) Heatmap plots of relative gene expression profiles withR23 expression change, p% 0.001, and FDR% 0.05 between ontogeny stages.
(C) Correlation between differences in DNA methylation of core promoters, promoter regions, and gene loci with expression.
(D) Genes showing significant changes in DNA methylation expressed in R1 of 39 hematopoietic cell types during transitions of ontogeny. Genes
expressed in HSCs and downstream cells (leftmost of each comparison group) were categorized as significantly higher in HSCs compared to downstream
cells (HSC higher), significantly higher in downstream cells compared to HSCs (Downstream higher), and having no significant changes in expression.
Significant expression differences were defined as R1.5-fold average expression with p % 0.01. Remaining genes were exclusively expressed in
HSCs (HSC only, middle of each comparison group), or exclusively expressed in downstream progeny (Downstream only, rightmost of each comparison
group).
(E) Representative genes with significant DNA methylation differences in old compared to young HSCs expressed exclusively in downstream
cells. DNA methylation differences and gene expression pattern in hematopoiesis are shown (Seita et al., 2012). Gene regions presented are Blnk,
(legend continued on next page)
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identified as differentially expressed in the transitions from
FL-HSCs to young HSCs, and young to old HSCs, respectively
(Figure 2B and Table S5). We next correlated differences in
gene expression to DNA methylation and found no correlation
in the genes differentially expressed during the FL-HSC to young
HSC transition, andwe found only amodest negative correlation,
which was most pronounced at core promoter and promoter
regions, in the transition from young to old HSCs (Figures 2C
and S3B). These results are consistent with previous studies
demonstrating little global correlation between gene expression
and DNA methylation in diverse cell types (Bock et al., 2012;
Challen et al., 2012; Deaton and Bird, 2011).
Our functional data, combined with our observation that DNA
methylation at chromatin regions associated with downstream
lineages was altered during HSC aging (Figure 1), raised the
possibility that the differential methylation observed during
HSC ontogeny may target genes expressed in downstream
progeny of HSCs. We therefore sought to explore the relation-
ship between the DNA methylation changes observed during
HSC ontogeny and gene expression throughout hematopoiesis.
Toward this we used microarray data, generated by others and
ourselves, of 39 different FACS-purified hematopoietic cell
types comprising the vast majority of hematopoietic stem,
progenitor, and effector cells (Seita et al., 2012) (Figure S3C).
We mapped the significant gains and losses of DNA methylation
during HSC ontogeny to gene loci and then correlated these
DNA methylation changes to gene expression in each of the
39 hematopoietic subsets. This analysis revealed that the
largest numbers of genes showing significant gains or losses
of DNA methylation were expressed in HSCs and their down-
stream progeny (Figure 2D and Table S6). Of these, it was none-
theless striking that in all cases, the vast majority of these genes
were more highly expressed in downstream hematopoietic
progenitors and effectors than in HSCs themselves (R1.5-
fold, p % 0.01, Figure 2D). Interestingly, only very few genes
differentially DNA methylated during HSC ontogeny were exclu-
sively expressed in HSCs (Figure 2D). In striking contrast, a large
number of DNA methylated genes were exclusively expressed
in downstream progenitor and effector cells, but not in HSCs
themselves (Figure 2D). Among this latter class were genes
important for the development, specification, and function of
diverse hematopoietic cell types, including lymphoid and
erythroid lineages, both of which are diminished upon hemato-
poietic aging in mouse and man (Figures 1C and S1D) (Beerman
et al., 2010b; Ewing and Tauber, 1964). For example, old HSCs
showed significant gains of DNA methylation at the core
promoter of Blnk, a signal adaptor molecule that is required
for B cell development (Pappu et al., 1999) and only expressed
downstream of HSCs in the B cell lineage starting at the CLP
stage (Figure 2E). Another interesting gene expressed down-
stream of HSCs that gained methylation in old HSCs, this time
within the promoter region and gene body, was Irf8 (Figure 2E),
which encodes a transcription factor that upon conditional dele-chr19: 41,060,000–41,072,000; Irf8, chr8: 123,248,000–123,277,000; and Ank1
methylation are denoted with asterisks (*). Transcription start sites (TSS, tall arro
Promoter Region: 20 kb of TSS; Core Promoter: 5 kb to +1 kb of TSS; Gene
See also Figure S3, Table S5, and Table S6.tion leads to impaired B cell development and concomitant
skewing to myeloid fates (Wang et al., 2008). In contrast,
Ank1, which is strictly expressed in erythroid progenitors and
plays a critical role in erythroid development (Rank et al.,
2009), showed DNA hypermethylation only within the gene
body in old HSCs (Figure 2E).
Taken together, these results indicate that the DNA methyla-
tion dynamics underlying HSC ontogeny only modestly correlate
with gene expression in HSCs and instead largely target genes
exclusively or more highly expressed in downstream progenitor
and effector cells. This suggests that age-associated DNA
methylation changes in HSCs may predominantly influence the
transcriptional competence of genes that become activated
during HSC differentiation to defined lineages.
Induced HSC Proliferation Leads to Functional Decline
and DNA Methylation Changes that Closely Mimic
Physiological HSC Aging
In adults, HSCs are predominantly quiescent and cycle infre-
quently. Estimates suggest that adult HSCs undergo 5–20
divisions over the course of a 2 year life span (Foudi et al.,
2008; Wilson et al., 2008). To investigate the impact of cell divi-
sion on HSC function and DNA methylation, we treated young
adult mice with 5-Fluorouracil (5-FU), which selectively kills
cycling cells leading to HSC proliferation. To selectively drive
HSCs to different degrees of proliferation, mice received zero,
two (23), or four (43) administrations of 150 mg/kg of 5-FU at
3 week intervals, and 2 months after the final injection, HSCs
were subjected to functional and DNA methylation analysis (Fig-
ure 3A). BM analysis of 5-FU-treated mice showed that the
treated mice (23 and 43 5-FU) displayed an increased
frequency of LSK cells (Figure 3B), with an increased percentage
of HSCs and a decreased percentage of MPPFlk2+ (Figure 3C).
Interestingly, these changes model the changes in the primitive
stem and progenitor compartment of naturally aged mice (Fig-
ure 3C) (Beerman et al., 2010a; de Haan et al., 1997; Rossi
et al., 2005). However, unlike in normal physiological HSC aging
(Beerman et al., 2010a), costaining HSCs with CD150, which we
and others have previously shown can be used to subfractionate
functionally distinct HSCs subsets (Beerman et al., 2010a;Morita
et al., 2010), showed comparable HSC subset composition
between the untreated and 5-FU treated cohorts, indicating
that 5-FU treatment did not lead to experimental selection of
HSC subtypes (Figure 3D).
BM cells from treated and untreated mice were competitively
transplanted, which showed that the HSCs subjected to the
greatest proliferative challenge (43 5-FU) were impaired in their
total reconstitution potential in both the short term and long term
posttransplant (Figure 3E). These heavily challenged HSCs
also exhibited a skewing of their lineage potential (Figure 3F)
that closely mimicked physiologic HSC aging (Figure 1C).
Granulocyte chimerism, measured throughout the course of
the experiment, and BM reconstitution measured at 20 weeks
posttransplant revealed trends of diminished HSC functional, chr8: 24,251,000–24,257,000. Single CpGs with significant differential DNA
w), untranscribed regions (white boxes) and exons (black boxes) are shown.
Body: within gene.
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Figure 3. Increased HSC Proliferation Leads to Functional Decline and Differential DNA Methylation that Recapitulates Physiological
HSC Aging
(A) Schematic overview of experimental design.
(B–D) Bone marrow analysis of mice receiving four (43), two (23) or zero (03) administrations of 5-fluorouracil (5-FU) (n = 8) 2 months postfinal 5-FU admin-
istration. Shown are (B) the primitive LSK compartment and (C) breakdown of the primitive LSK compartment as follows: HSC (CD34 Flk2), MPPFlk2 (CD34+
Flk2) and MPPFlk2+ (CD34+ Flk2+), and LSK compartment of old mice (right), with (D) CD150 subsets of HSCs (Beerman et al., 2010a; Morita et al., 2010).
(E and F) Total reconstitution of recipientmice transplanted with 13 106WBMcells frommice that received 43, 23, or 03 5-FU against 13 106 young competitor
BM cells (E) and lineage contribution to B cells (B220+), myeloid cells (Mac1+), and T (CD3+) cells at indicated times posttransplant (F) (n = 6 recipients each).
(G) Number of 1 kb tiles with significant differential DNA methylation as determined by pairwise comparisons between HSCs after 5-FU receipt and HSCs from
untreated young (Y) mice. Total comparisons with sufficient DNA methylation information for both populations were as follows: Y-23 = 84,510, Y-43 = 88,704.
(H) Overlap of 1 kb intervals with significant gains or losses of DNA methylation in comparisons between enforced HSC proliferation (23 or 43 5-FU) either in
untreated young HSCs or during HSC aging (young to old) showing p values, Log2Odds scores, and total comparisons.
Significant differences: *p < 0.05, **p < 0.01, ***p < 0.001 (t test). Error bars show SEM. See also Figure S4.
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similar to physiologic aging, yet did not reach statistical signifi-
cance (Figures 1D, 1E, S4A, and S4B).418 Cell Stem Cell 12, 413–425, April 4, 2013 ª2013 Elsevier Inc.DNA methylation profiling of HSCs purified from 5-FU-treated
and untreated control mice was analyzed in pairwise compari-
sons as described above, which revealed significant differential
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DNA Methylation Changes Underlie HSC Agingmethylation at several thousand loci (Figures 3G andS4C). Aswe
had observed during physiological aging (Figure 1H), regions
that gained DNA methylation predominated the observed
changes (Figure 3G). This observation, combined with the func-
tional similarity to physiological HSC aging, prompted us to
examine whether the sites altered after 5-FU-induced HSC
proliferation overlapped with those altered during physiologic
HSC aging. Strikingly, a highly significant number of loci that
either gained or lost methylation were shared between physio-
logic HSC aging and young HSCs subjected to the proliferative
challenge of repeated 5-FU administration (Figure 3H). Cumula-
tively, these results indicate that both HSC functional decline and
age-associated DNA methylation changes are largely HSC
proliferation dependent.
The Replicative Limits of HSCs Are Proliferative History
Dependent, Yet Telomere Length Independent
It has previously been shown that HSCs transplanted at lower
numbers in primary transplants are subjected to increasingly
greater proliferative stress (Pawliuk et al., 1996). We reasoned
that if the proliferative history of HSCs played a central role in
limiting their functional potential and/or altering their DNA meth-
ylation landscape, this would be revealed in such an experi-
mental setting. We therefore purified HSCs from young mice,
transplanted limiting numbers of the HSCs over a 50-fold range
(500, 50, or 10 cells) into primary recipients, purified them
20 weeks after transplant (Figure S5A), and subjected them to
either DNAmethylation analysis or serial transplantation (Figures
4A). BM analysis of the primary recipients 20 weeks post-
transplant showed that, as expected, the extent of donor recon-
stitution correlated with number of HSCs originally transplanted
(Figure 4B). As in our 5-FU experiments (Figure 3D), examination
of the HSC compartment revealed that different HSC subtypes
as defined by costaining with CD150 (Beerman et al., 2010a;
Morita et al., 2010) were similarly represented regardless of
the original HSC numbers transplanted (Figure S5B). Donor-
derived HSCs were FACS purified and equal numbers of
HSCs (200 cells) were competitively transplanted into secondary
recipients (Figure S5A). Peripheral blood analysis of secondary
recipients showed an inverse correlation between HSC prolifer-
ative history and reconstitution potential—in other words, HSCs
that had undergone greater transplant-induced proliferative
stress in the primary transplants performed less well, on a per
cell basis, in the secondary transplants (Figure 4C). The func-
tional impact of these differences in HSC proliferative history
was also reflected throughout the secondary transplants by
granulocyte chimerism, which further demonstrated that HSCs
from the original 50 and 10 cell transplants became functionally
exhausted during the course of secondary reconstitution (Fig-
ure 4D). Five months postsecondary transplant, this was con-
firmed with BM analysis, which showed that only the HSCs
that had been subjected to the least amount of proliferative chal-
lenge in the primary transplants (500 HSCs) were able to effec-
tively repopulate the BM, whereas those transplanted at the
lower doses (50 and 10 HSCs) gave rise to only minimal BM
reconstitution in secondary hosts (Figure 4E). These results
were largely recapitulated when HSCs from old mice were trans-
planted at 500, 50, and 10 cell doses and then functionally eval-
uated by serial transplantation using a similar experimentalapproach (Figures S5A–S5C). These experiments again demon-
strated that only HSCs transplanted at the highest dose
(500 HSCs) in the primary transplants were able to give rise to
sustained long-term multilineage reconstitution upon secondary
transplantation (Figures S5D and S5E).
Although telomere length limits the replication potential of
many human cell types, this is generally not believed to be
the case in C57BL/6 mice, which are relatively short-lived
and have long telomeres. Although progressive telomere attri-
tion has been observed in HSCs during serial transplantation
(Allsopp et al., 2001), telomere length does not ultimately
appear to limit the replicative capacity of HSCs, which exhaust
during serial transplantation even under settings where telo-
mere length is maintained through enforced expression of
telomerase (Allsopp et al., 2003). Nonetheless, the prolifera-
tion-dependent HSC functional exhaustion observed in our
experiments prompted us to examine telomere length. Given
the limited donor-derived cell numbers in our transplant exper-
iments, we used a recently developed single-cell qPCR-based
strategy to measure relative telomere length (Norddahl et al.,
2012) using donor-derived granulocytes as a surrogate for
quantifying telomere length in HSCs (Figures S6A–S6D)
(Bryder et al., 2006) in both the primary and secondary HSC
transplants described above. Strikingly, regardless of original
transplant cell number (500, 50, or 10 HSCs), no significant
differences were observed in the relative telomere length
of donor-derived granulocytes from either the primary or
secondary transplants (Figure 4F), despite the fact that the
HSCs derived from the mice transplanted at low cell numbers
eventually reached their replicative limits and became ex-
hausted (Figure 4D).
Taken together, these results indicate that the total replicative
potential of HSCs is ultimately limited by their proliferative
history, yet appears to be telomere length independent.
The Replicative Limit of HSCs Is Associated with Global
DNA Hypomethylation
DNA methylation analysis of HSCs purified after primary trans-
plantation in these experiments revealed HSCs from young or
old donors subjected to increasingly greater transplantation-
induced proliferative stress (500 HSCs < 50 HSCs < 10
HSCs) showed significant stepwise global hypomethylation in
comparison to steady-state young or old HSCs (Figures 5A
and S5F). Consistent with this, pairwise comparisons to
steady-state young HSCs showed that regions with significant
losses of DNA methylation upon transplant-induced HSC prolif-
eration predominated in all cases (Figures 5B and S5G). These
results contrast with our observations of normal physiologic
HSC aging (Figures 1G and 1H), and are more in line with the
global DNA hypomethylation reported to accompany aging in
somatic cells and tissues (Gonzalo, 2010). Nonetheless,
comparisons of the loci showing significant differential DNA
methylation in these experiments to those observed during
steady-state HSC aging revealed a highly significant overlap
of specific loci that both gained or lost DNA methylation (gains
and losses) (Figures 5C and S5H). These results further support
the interpretation that the changes in the DNA methylation
landscape observed during HSC aging are, to a great extent,
driven by HSC proliferation.Cell Stem Cell 12, 413–425, April 4, 2013 ª2013 Elsevier Inc. 419
Figure 4. The Replicative Limits of HSCs Are Proliferative History Dependent, Yet Independent of Telomere Length
(A) Schematic overview of experimental design.
(B) Total donor BM reconstitution, 20weeks posttransplant, of recipient mice transplantedwith 500, 50, or 10 young HSCs (CD45.1) and 500, 50, and 10 old HSCs
(CD45.2) (respectively) and a radio-protective dose of Sca1-depleted bone marrow cells (CD45.1/2).
(C and D) Competitive secondary transplantation of 200 donor-derived HSCs from the primary transplants of 500, 50, or 10 young HSCs (n = 7, 4, or 5 recipients,
respectively) against 2 3 105 competitor BM cells showing (C) total reconstitution and (D) granulocyte chimerism.
(E) Total donor BM reconstitution of the recipients described in (B) and (C) 20 weeks postsecondary transplant.
(F) Single-cell qPCR telomere length analysis of donor-derived granulocytes isolated from primary recipients of 500, 50, or 10 young HSCs (left, nR14) or
secondary (right, nR28) recipients measured at 12 and 8 weeks posttransplant, respectively.
Significant differences: *p < 0.05, **p < 0.01, ***p < 0.001 (t test). Error bars show SEM. See also Figures S5 and S6.
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DNA Methylation Changes Underlie HSC AgingSpecific DNA Hypermethylation of PRC2 Target Genes
in HSCs after Enforced Proliferation and Aging
To further explore the degree to which proliferative history
shapes the epigenetic landscape of HSCs during aging, we per-
formed ameta-analysis comparing the DNAmethylation data we
generated for normal physiologic HSC aging to all the data sets
generated for HSCs subjected to experimentally enforced prolif-
eration (EP). These included data sets of HSCs derived from the
5-FU treated mice (23 and 43 5-FU) (Figure 3) and HSCs (both
young and old) derived from themice transplanted with 10, 50, or420 Cell Stem Cell 12, 413–425, April 4, 2013 ª2013 Elsevier Inc.500 HSCs (Figure 4, Figure 5, and Figure S5). This analysis re-
vealed very significant overlaps of loci that either gained or lost
DNA methylation during physiological aging or after EP (Fig-
ure 6A), supporting the conclusion that locus-specific changes
in the DNA methylome during HSC aging are, to a significant
degree, proliferation dependent. Our results demonstrating
that HSC functional potential is also largely dependent on the
proliferative history of HSCs (Figures 3E and 3F, Figures 4B–
4E, and Figures S4A, S4B, S5D, and S5E) prompted us to
examine the genes showing aging- and proliferation-dependent
Figure 5. The Replicative Limit of HSCs
Is Associated with Global DNA Hypomethy-
lation
(A) Bean plot of global DNA methylation of steady-
state young HSCs and donor-derived HSCs
isolated from primary recipients of 500, 50, or 10
transplanted young HSCs.
(B) Number of 1 kb tiles with significant DNA
methylation differences in pairwise comparisons
of HSCs derived from initial transplants of 500, 50,
and 10 young HSCs to steady-state young HSCs.
Total comparisons with sufficient DNAmethylation
information for both populations are as follows:
Y-Y500= 98,301, Y-Y50 = 97,872, Y-Y10 =89,051.
(C) Overlap of 1 kb intervals with significant
differential DNA methylation in comparisons
between young transplanted HSCs (500, 50, or 10
HSCs) to young HSCs, and also during HSC aging
(young to old), showing p values, Log2Odds
scores, and total comparisons.
See also Figure S5.
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DNA Methylation Changes Underlie HSC Agingdifferential DNA methylation more closely. To this end, we per-
formed gene set enrichment analysis (GSEA) on the genes that
consistently gained or lost DNA methylation during HSC aging
and after subjection to EP (438 and 97 loci, respectively) (Fig-
ure 6A). Whereas no significant enrichments were associated
with the genes that lost DNAmethylation, the 438 loci that gained
DNA methylation were highly enriched with loci marked by
H3K27 and bound by EED and SUZ12 in human embryonic
stem cells—which together represent the epigenetic mark and
two of the core components of Polycomb repressive complex
2 (PRC2) (Figure 6B, Table S7).
Recent studies have shown that chromatin-bound PRC2 and
DNA methylation at CpG-dense regions are mutually exclusive
(Brinkman et al., 2012; Meissner et al., 2008; Weinhofer et al.,
2010). The antagonistic nature of PCR2 and DNA methylation,
combined with our results showing that PRC2 targets were
selectively DNA hypermethylated upon enforced HSC prolifera-
tion and during HSC aging, prompted us to examine the ex-
pression of PRC2 core components Ezh2, Suz12, and Eed by
qRT-PCR in HSCs purified from young and old mice. We
reasoned that diminished levels of PRC2 might facilitate DNA
hypermethylation at these specific loci in old HSCs. Consistent
with this idea, we found that these PRC2 core components were
significantly age downregulated in HSCs, with Ezh2 showing the
greatest fold difference (3.7-fold) and Suz12 and Eed showing
more modest downregulation (both 1.4-fold) (Figure 6C).
Taken together, these results demonstrate that PRC2 target
genes are selectively DNA hypermethylated in a proliferation-
dependent manner during HSC aging, concomitant with age-
diminished expression of the PRC2 complex.
DISCUSSION
Numerous lines of evidence have suggested that age-dependent
epigenomic alterations may mechanistically contribute to the
functional decline of HSCs during aging, yet the paucity ofHSCs and technical challenge of profiling the epigenomes
of such rare cells has precluded analysis. Herein, we have
addressed this issue by using high-throughput bisulfite
sequencing to generate DNA methylation profiles of purified
HSCs from different stages of ontogeny. To provide functional
context to the resulting DNA methylation data, we performed
functional experiments on purified HSCs in parallel.
In contrast to FL-HSCs and young adult HSCs, which showed
robust activity in transplantation assays with comparable lineage
predisposition and reconstituting potential, purified HSCs from
old mice showed substantially diminished repopulating activity
and a skewing of lineage potential consistent with previous
reports (Beerman et al., 2010a; Muller-Sieburg et al., 2004; Rossi
et al., 2005; Sudo et al., 2000). Given that the FL is a fundamen-
tally different niche than the BM microenvironment from which
both young and old adult HSCs were isolated, these results
suggest that chronological aging has greater impact on HSC
functional potential than microenvironmental influences. With
this said, HSCs of fetal origin do differ from adult HSCs in
a number of respects, including immunophenotype, cell cycle
status, and ability to give rise to distinct subsets of B cells and
T cells (Rossi et al., 2008). It should also be noted that the
BM niche of mice changes substantially with advanced age,
becoming osteoporotic and infiltrated with adipose tissue.
Nonetheless, our results combined with evidence demonstrating
the cell-autonomous nature of HSC aging: HSCs from old mice
exhibit functional impairment even upon transplantation into
young recipients (Rossi et al., 2005), which argues that chrono-
logical aging is a major factor underlying HSC functional decline.
Given the aforementioned differences in niche and functional
potential of HSCs during ontogeny, it was interesting to see
that the DNA methylation landscape of HSCs was very stable
from fetal development through to old age, although a slight
but significant degree of global DNA hypermethylation was
observed in old HSCs. This latter observation contrasts with
numerous reports demonstrating that somatic tissues and cellsCell Stem Cell 12, 413–425, April 4, 2013 ª2013 Elsevier Inc. 421
Figure 6. Targeted DNA Hypermethylation of PRC2 Regulated Genes Accompanies Proliferation-Dependent HSC Aging
(A) Overlap of 1 kb intervals with significant differential methylation in composite comparisons of HSCs subjected to experimentally enforced proliferation (EP) to
young HSCs (Y) (Y-EP) and during HSC aging (Y-O) showing p values, Log2Odds scores, and total comparisons. Comparisons include 1 kb regions with
methylation information in young and oldmice, and at least six of the eight samples subjected to EPwith threshold significance set at n-2with significant changes.
(B) Gene set enrichment analysis of the 438 loci with consistent gains of methylation after EP and during HSC aging identified in (A) showing Q values and
Log2Odds scores.
(C) qPCR-generated relative expression values of PRC2 components from young and old HSCs showing individual measurements of sorted HSCs (10 cells),
(nR 23).
Significant differences: *p < 0.05, **p < 0.01, ***p < 0.001 (t test). Error bars show SEM. See also Table S7.
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DNA Methylation Changes Underlie HSC Agingderived from aged animals frequently present global DNA hypo-
methylation with advanced age (Gonzalo, 2010). We propose
that these differences may reflect the fact that in contrast to
somatic cells, which are largely postmitotic, the mitotic potential
of HSCs extends far beyond a single life span (Harrison and
Astle, 1982). In support of this model, DNA hypomethylation
ensued when we experimentally pushed HSCs to their replica-
tive limits by serially transplanting limited numbers of HSCs
(Figure 7).
Despite the overall stability of the HSC DNA methylation land-
scape, minor fractions of the genome were specifically, differen-
tially methylated at different stages of HSC ontogeny. Consistent
with the functional comparability of FL and young HSCs, the
genomic regions differentially methylated at this transition did
not overtly reflect DNA methylation differences that would influ-
ence function but rather appeared more suggestive of a process
of ongoing developmental restriction: young HSCs gained DNA
methylation on regions associated with nonhematopoietic line-
ages, whereas significant losses of DNA methylation were en-
riched at genomic regions associated with blood cell production.
In contrast, the transition to old age was marked by gains of
DNAmethylation at genomic regions associated with open chro-
matin in lymphoid (B cell and T cell) and erythroid lineages, all of
which are diminished during aging (Figures 1C and S1D)
(Beerman et al., 2010b). These data suggest that increased
methylation at such loci might restrict the potential of old
HSCs by inhibiting differentiation toward these lineages, pos-
sibly by modulating chromatin accessibility to transcriptional
programs active in downstream cells during differentiation.
Consistent with this idea, we found that the vast majority of
genes differentially methylated during HSC ontogeny were either
exclusively expressed downstream of HSCs or expressed at
higher levels in progenitor and/or effector cells relative to
HSCs. This was an unexpected discovery because it suggests
that DNA methylome alterations occurring specifically in HSCs
during ontogeny may directly manifest their impact on hemato-
poietic aging by altering gene programs and transcrip-
tional networks activated during differentiation in downstream422 Cell Stem Cell 12, 413–425, April 4, 2013 ª2013 Elsevier Inc.progeny, but not in HSCs themselves. With this said, we did
not observe overt differences in lineage potential of FL and
young HSCs, which were also marked by DNAmethylation alter-
ations of genes expressed downstream of HSCs. One potential
explanation is that the observed methylation differences in
FL-HSCs may influence their properties in a niche-specific
manner and have little impact on the potential of these cells after
transplantation into adult recipients, which we used to assay
their function. It will also be interesting to determine how
ontogeny-associated differences in HSC subtypes (Beerman
et al., 2010a; Benz et al., 2012; Challen et al., 2010; Dykstra
et al., 2007; Morita et al., 2010; Muller-Sieburg et al., 2004;
Sudo et al., 2000) contribute to the DNA methylation patterns
we observed in this study.
Though the replicative potential of HSCs is extensive, it is
exhaustible. Similar to the finite limits of cell doubling (Hayflick
and Moorhead, 1961), serial transplantation experiments have
demonstrated that HSCs have a finite limit to their replication
potential (Harrison and Astle, 1982). However, while telomere
attrition is known to limit the replicative capacity of many human
cell types, preservation of telomere length through enforced
expression of telomerase in murine HSCs does not extend their
replicative capacity (Allsopp et al., 2003). This demonstrates that
another mechanismmust underlie the limits of HSC self-renewal.
Using settings of experimentally enforced HSC proliferation, we
found that the repopulating potential, lineage potential, and total
self-renewal capacity of HSCs is dependent on their divisional
history, yet appears to be telomere length independent. Whether
a developmentally preordained, fixed number of HSC cell divi-
sions exists, or whether the limits of HSC self-renewal are
instead underwritten by mechanisms that could be fostered by
cell division, such as DNA damage accumulation, is currently
unclear. Nonetheless, the fact that HSC self-renewal is ultimately
limited by replicative history may explain why engineered muta-
tions leading to loss of HSC quiescence or sustained cycling
frequently lead to premature HSC exhaustion (Rossi et al., 2012).
Unexpectedly, we also found that age-associated alterations
of the DNA methylation landscape were dependent, to a large
Figure 7. Model of the Changing DNAMeth-
ylation Landscape and Functional Potential
of HSCs during Ontogeny
Schematic representation of DNA methylation
changes in HSCs (white lollipop, unmethylated
CpGs; black lollipop, methylated CpGs) and the
functional alterations associated with HSC
ontogeny as indicated (y axes).
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DNA Methylation Changes Underlie HSC Agingextent, on the proliferative history of HSCs. This was surprising
in light of the evidence demonstrating the quiescent status of
adult HSCs during homeostasis and studies showing that
HSCs undergo only limited cell divisions over the life span of
adult mice (Foudi et al., 2008; Wilson et al., 2008). Strikingly,
we found that physiological aged HSCs, as well as HSCs
that endured enforced divisional history, were consistently
DNA hypermethylated at loci identified as targets of PRC2.
Though not conclusive, the reported antagonism between
PRC2 and DNA methylation, combined with our data showing
diminished expression of the PRC2 core components Ezh2,
Suz12, and Eed during aging, suggests that PRC2-mediated
repression at these loci may diminish with HSC age and allow
the DNA methylation machinery to more readily access these
sites.
Evidence that PRC2 may be more broadly involved in regu-
lating the aging, replicative limits, and pathophysiology of
diverse cell types is mounting. For example, downregulation of
EZH2 leads to BMI1-dependent derepression of the INK4A-
ARF locus in human and mouse cells undergoing senescence
(Agherbi et al., 2009; Bracken et al., 2007), whereas continued
ectopic expression of Ezh2 extends the replicative limits of
HSCs (Kamminga et al., 2006). Furthermore, a recent study
examining DNA methylation in healthy and cancer patients re-
vealed an age-associated increase in DNA hypermethylation of
PRC2 targets (Teschendorff et al., 2010), suggesting that this
may be a common feature of aging in diverse cell types. Gains
of DNA methylation of PRC2 targets have also been shown to
be characteristic of diverse cancers (Deaton and Bird, 2011),
whereas loss-of-function mutations in PRC2 core components
have been found in a variety of myeloid diseases, including acute
myelogenous leukemia and myelodysplastic syndrome (MDS)—
the prototypic HSC disease of the elderly (Shih et al., 2012).
These facts, together with the fact that mutations in TET2, which
encodes a DNA demethylase, are among the most common
found in MDS patients (Shih et al., 2012), indicate that aberrant
DNA hypermethylation in HSCs is likely central to the etiology
of disease in these patients. This has been affirmed in clinical
trials demonstrating that subsets ofMDS patients are responsive
to DNA hypomethylating agents (Fukumoto and Greenberg,
2005).
Given the striking functional and molecular conservation of
HSC aging in mice and humans (Pang et al., 2011), it will beCell Stem Cell 12, 413–important to determine if the alterations
of the DNA methylation landscape we
report here similarly underlie human
HSC aging and/or progression to dis-
ease. If so, the plasticity and potential
reversibility of DNA methylation opensthe possibility of therapeutically targeting the DNA methylome
or its regulators as a means of restoring function to aged HSCs.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 males were used as transplant donors and for DNA methylation
analysis. Young mice were 12–14 weeks of age. Old mice (22–26 months)
were obtained from the National Institute of Aging (Bethesda, MD). All mice
were maintained according to Harvard Medical School Animal Facility proto-
cols. Procedures were performed with consent from local ethics committees.
5-FU was administered at 150 mg/kg by intraperitoneal injection.
HSC Purification
Lineage depletion was performed using biotin-conjugated antibodies against
CD3, CD4, CD8, B220, Ter119, Mac1, Gr1, and Il7ra and streptavidin-
conjugated magnetic beads (Miltenyi). Lineage-depleted cells were stained
with antibodies against Sca1, c-kit, CD34, Flk2, CD48, CD150, fluorescently
labeled streptavidin, propidium iodide (PI), and, in transplant settings,
CD45.1 and CD45.2. HSCs were sorted as PIlinc-kit+Sca1+CD34
Flk2CD150+ on a FACS Aria II (Becton Dickinson). E14.5 FLs were lineage
depleted using biotin-conjugated antibodies to CD3, CD4, CD8, B220,
Ter119, Gr1, and Il7ra and streptavidin-conjugated magnetic beads, and
then stained with antibodies against Sca1, c-kit, Mac1, CD48, CD150, fluores-
cently labeled streptavidin, and PI. FL-HSCs were isolated as PIlinc-kit+
Sca1+CD48 CD150+Mac1+. PI was used to exclude dead cells. HSCs were
double sorted for purity. FACS data were analyzed with FlowJo software
(Tree Star, Ashland, OR).
Transplantation Experiments
HSCs were transplanted at indicated cell numbers into lethally irradiated
(10 Gy) recipients against 2 3 105 competitor BM cells or 3 3 105 Sca1-
depleted BM cells as indicated. Secondary transplants were performed
competitively. BM transplant recipients were injected with a total of 2 3 106
cells at a 1:1 ratio of donor to competitor. Peripheral blood analysis was per-
formed at 4 week intervals posttransplant with antibodies against Ter119,
B220, Mac1, Gr1, CD3, CD45.1, CD45.2, and PI.
DNA Methylation Analysis
RRBS was performed according to a previously published protocol (Gu et al.,
2011; Smith et al., 2009, 2012). The raw sequencing reads were aligned using
Maq’s bisulfite alignment mode (Li et al., 2008), and DNA methylation calling
was performed using custom software (Gu et al., 2010). DNA methylation
analysis was performed as previously described (Bock et al., 2012).
Genome-wide Expression Profiling
FACs-purified HSCs from FL (E14.5), young mice (3.5 months), and old mice
(25 months) were sorted into TRIzol (Invitrogen). RNA was purified and double
amplified (Affymetrix) and hybridized to Affymetrix Mouse 430 2.0 arrays.425, April 4, 2013 ª2013 Elsevier Inc. 423
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DNA Methylation Changes Underlie HSC AgingResulting cel files were normalized in R using gcRMA. Comparative analysis
was performed using GenePattern (Reich et al., 2006). Normalized files were
preprocessedwith a fold change of%2 and a delta of%50 (linear array values).
Comparative marker selection computed p values based on all possible
sample permutations. Thresholds for significance were set as the following
filters: FDR(BH)% 0.05, Feature p% 0.001, and Fold ChangeR 2.
Expression data of 39 hematopoietic cell types, GSE34723 (Seita et al.,
2012), was renormalized using R. Probe sets used for comparison analysis
were determined to be the closest probe set within +10 kb of each differentially
methylated region, a placement that also accounted for probe set strand
information. A threshold of linear expression value R50 was used. Pairwise
t test comparisons of the expression of each non-HSC cell type to HSCs
were performed, and the threshold for significant differences was as
follows: fold change R1.5 and p % 0.01. Absolute gene expression images
(Figure 2) were generated using ‘‘Gene Expression Commons’’ (Seita et al.,
2012).
Quantitative Real-Time PCR
Ten cells were sorted into a modified lysis buffer (Warren et al., 2006), and
genes of interest were preamplified using Cells Direct One-step qRT-PCR kit
(Invitrogen) with primers spanning intron-exon boundaries designed using
PrimerBlast (http://www.ncbi.nlm.nih.gov/tools/primer-blast/). Real-time
PCR was performed using nested primers and Kapa SYBR Fast (Kapa
Biosystems) with 4 ml of a 103 dilution of preamplified 10 cell samples. g-actin
was used to normalize expression. DcT values were generated for each
sample and DDcT values are presented.
Telomere Length Assays
Single-cell telomere assays were measured by qPCR as recently described
(Norddahl et al., 2012). See also Supplemental Experimental Procedures.ACCESSION NUMBERS
Raw and processed DNAmethylation data (FASTQ and BED files) are available
at GEO under accession number GSE44117.SUPPLEMENTAL INFORMATION
Supplemental Information for this article includes six figures, seven tables, and
Supplemental Experimental Procedures and can be found with this article
online at http://dx.doi.org/10.1016/j.stem.2013.01.017.
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